WM Guidelines – Patient Factsheet
A factsheet for patients about the WM treatment guidelines
British Society for Haematology Guidelines for WM diagnosis and management
New (Dec 2021) guidelines produced by the British Society for Haematology for the diagnosis and management of Waldenstrom's macroglobulinaemia
The Rory Morrison WMUK Registry Report 2021
The 2nd report from the Rory Morrison WMUK Registry
2021 WMUK Patient-Doctor Summit programme
Browse the programme to the 2021 WMUK Patient-Doctor Summit
How to register to the Patient-Doctor Summit
Find out how to register to the virtual 2021 WMUK Patient-Doctor Summit
WMUK Email Discussion Forum – User Guidelines
24 Jan 2021 Joining instructions and user guidelines for the WMUK sponsored Groups.io email discussion forum.
Leaving WMUK a gift in your Will
20 Jan 2021 By leaving a gift to WMUK in your Will, you can make a huge difference to the lives of people affected by Waldenstrom’s macroglobulinaemia.
Factsheet: Testing for coronavirus
17 Sep 2020 Dr Shirley D’Sa, WM lead clinician at University College London Hospitals (UCLH) and WMUK trustee, explains the science behind testing for coronavirus.
Factsheet: Waldenstrom’s macroglobulinaemia (WM) and COVID-19: Are people with WM more at risk of complications?
11 Sep 2020 Dr Dima El-Sharkawi, WMUK trustee and Consultant Haematologist at the Royal Marsden Hospital, London, looks to answer some of the questions currently being asked of doctors and nurses in clinic consultations regarding how much people with WM should still be avoiding others.
WEBINAR RECORDINGS: WM and COVID-19
26 Jun 2020 On Friday 19 June, over 260 people joined our webinar, in partnership with Lymphoma Action, to hear our panel of UK experts answer some of the most commonly asked questions around COVID-19 and Waldenstrom's macroglobulinaemia (WM).